PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsheart arrest
MeSH D006323 - heart arrest
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006331:Heart diseases
0 Companies
0 Drugs
Success rate
D006323: 
Heart arrest
D016757:Sudden death cardiac
0 Companies
0 Drugs
Success rate
D058687:Out-of-hospital cardiac arrest
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MPhenylephrine, Isoproterenol Duo-medihaler  1982-01-01   
Isoproterenol Isoproterenol  1982-01-01   
Epinephrine Medihaler-epi  1982-01-01   
Abbott BiotherapeuticsLidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
Isoproterenol Norisodrine Aerotrol  1982-01-01   
AbbVieAtropine Atropine  1987-01-30   
Atropine, Meperidine Atropine Demerol  1982-11-26   
Isoproterenol Norisodrine  1982-01-01   
Able LaboratoriesAtropine, Diphenoxylate Diphenoxylate Atropine  2000-11-27   
Accord HealthcareAtropine Atropine  2021-07-26   
Adamis PharmaceuticalsEpinephrine Symjepi 2036-10-20 2017-06-15   
Alcon ResearchAtropine Isopto Atropine  2016-12-01   
AllerganAtropine, Diphenoxylate Diphenoxylate Atropine  1982-01-01   
Lidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
AlpharmaIsoproterenol Isoproterenol  1982-01-01   
Atropine, Diphenoxylate Lomanate  1982-01-01   
American RegentAtropine Atropine  2022-05-26   
Epinephrine Epinephrine  2018-07-06   
Isoproterenol Isoproterenol  2022-10-19   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
70%
14/20
Phase 2
63%
15/24
Phase 3
18%
6/33
Approved: 3Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
AbbVie
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use